GCK and type 2 diabetes mellitus: For studies comparing GCK‐MODY to type 2 diabetes, the results showed that patients with the GCK mutation were around 2.46 years younger than type 2 diabetes patients at diagnosis, which agrees with the typically younger‐onset age for MODY patients compared to type 2 diabetes.